CANY
INVA icon

Caxton Associates (New York)’s Innoviva INVA Stock Holding History

Caxton Associates (New York)’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$442K Sell
25,480
-2,044
-7% -$39.2K 0.01% 355
2024
Q3 		$531K Sell
27,524
-80,753
-75% -$1.49M 0.02% 354
2024
Q2 		$1.78M Buy
108,277
+72,716
+204% +$1.13M 0.06% 163
2024
Q1 		$542K Buy
35,561
+19,076
+116% +$300K 0.03% 309
2023
Q4 		$264K Buy
+16,485
New +$231K 0.01% 406
2023
Q2 		– Sell
-23,860
Closed -$268K – 569
2023
Q1 		$268K Buy
23,860
+8,695
+57% +$106K 0.04% 373
2022
Q4 		$201K Buy
+15,165
New +$199K 0.01% 383
2022
Q3 		– Sell
-47,944
Closed -$708K – 573
2022
Q2 		$708K Sell
47,944
-90,391
-65% -$1.48M 0.07% 197
2022
Q1 		$2.68M Buy
138,335
+93,807
+211% +$1.68M 0.22% 31
2021
Q4 		$768K Hold
44,528
– – 0.08% 169
2021
Q3 		$744K Buy
+44,528
New +$666K 0.08% 142
2020
Q3 		– Sell
-39,534
Closed -$553K – 412
2020
Q2 		$553K Sell
39,534
-2,410
-6% -$32.8K 0.05% 116
2020
Q1 		$493K Sell
41,944
-20,564
-33% -$272K 0.09% 165
2019
Q4 		$885K Buy
+62,508
New +$767K 0.12% 101
2018
Q4 		– Sell
-17,557
Closed -$268K – 378
2018
Q3 		$268K Buy
+17,557
New +$253K 0.02% 337
2018
Q1 		– Sell
-18,037
Closed -$256K – 376
2017
Q4 		$256K Buy
+18,037
New +$241K 0.01% 316

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Caxton Associates (New York)'s INVA Position: Q4 2024 in Review

Caxton Associates (New York) reduced its Innoviva (INVA) stake by 7.4% in Q4 2024, selling an estimated $39.2K and leaving 25,480 shares worth $442K. The position accounts for 0.01% of the portfolio, ranked #355.

Caxton Associates (New York) first reported a position in INVA in Q4 2017 and has held it in 16 quarters since. The position peaked at $2.68M in Q1 2022. 235 funds tracked by Wall St. Rank hold INVA as of Q4 2024.

  • Caxton Associates (New York) held 25,480 shares of Innoviva worth $442K as of Q4 2024.
  • Caxton Associates (New York) sold 2,044 Innoviva shares in Q4 2024, an estimated $39.2K.
  • Innoviva made up 0.01% of Caxton Associates (New York)'s portfolio in Q4 2024, its #355 holding.
  • Caxton Associates (New York) first reported a position in Innoviva in Q4 2017 and has held it in 16 quarters since.
  • Caxton Associates (New York)'s Innoviva position peaked at $2.68M in Q1 2022.
  • 235 funds tracked by Wall St. Rank held Innoviva as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.